MARKET
IPO

ODTX

Odyssey Therapeutics
ODTX
NASDAQ
Upcoming IPOs
Expected Listing Date: 2026-05-08
P/E
P/S
P/B
MARKET CAP
INDUSTRY
-
-
-
719.92M~809.91M
-
2026-04-17
Public Filing
View Prospectus
Pending
Offering
Price Range: 16.00~18.00
Shares to be Issued: 13.24M
2026-05-07
Offering End Date
Offering Price: Pending
Post IPO Outstanding: 44.99M
2026-05-08
Listed
No Data
About ODTX
Odyssey Therapeutics Inc is a United States-based biotechnology company. The Company operates as a clinical-stage biotechnology company that discovers and develops precision medicines for autoimmune, inflammatory diseases, and oncology. It also focuses on creating a pipeline of internally discovered product candidates. It uses a combination of deep biological computational tools, including artificial intelligence (AI) and machine learning (ML), to target difficult-to-drug pathways and create novel small molecule and protein therapeutics. Its diversified portfolio of programs, including OD-07656 (RIPK2 inhibitor), IRAK4 Scaffolding Inhibitor and TNFR2 Agonist and TSLP/IL-33 Antagonist.

Webull offers Odyssey Therapeutics stock information, including NASDAQ: ODTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ODTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ODTX stock methods without spending real money on the virtual paper trading platform.